Patient seta | Nb | IgG anti-MAAc n (%) | p | IgM anti-MAAc n (%) | p | IgA anti-MAAc n (%) | p |
---|---|---|---|---|---|---|---|
All RA | |||||||
Santiago | 517 | 31 (6.0) | < 10−310 | 76 (14.8) | < 10−20 | 37 (7.2) | < 10−150 |
Barcelona | 178 | 13 (7.3) | < 10−180 | 1 (0.6) | < 10−20 | 23 (12.9) | < 10−55 |
Thiele, 2015 [4] | 1720 | 1582 (92.0) | Ref | 654 (38.0) | Ref | 1256 (73.0) | Ref |
Anti-CCP+ | |||||||
Santiago | 332 | 18 (5.4) | < 10−240 | 65 (19.7) | < 10−10 | 29 (8.8) | < 10−110 |
Barcelona | 127 | 9 (7.1) | < 10−150 | 1 (0.8) | < 10−15 | 17 (13.4) | < 10−45 |
Thiele, 2015 [4] | 1340 | 1246 (93.0) | Ref | 549 (41.0) | Ref | 1018 (76.0) | Ref |
Anti-CCP− | |||||||
Santiago | 185 | 13 (7.0) | < 10−75 | 11 (5.9) | < 10−9 | 8 (4.3) | < 10−35 |
Barcelona | 51 | 4 (7.8) | < 10−35 | 0 (0) | < 10−5 | 6 (11.8) | < 10−10 |
Thiele, 2015 [4] | 380 | 334 (87.9) | Ref | 110 (28.9) | Ref | 239 (62.9) | Ref |